Aprea Therapeutics Inc APRE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/26/24 EDT
5.20quote price arrow down-0.15 (-2.80%)
Volume
4,734
52 week range
2.78 - 8.85
Loading...
  • Open5.20
  • Day High5.20
  • Day Low5.00
  • Prev Close5.35
  • 52 Week High8.85
  • 52 Week High Date03/01/24
  • 52 Week Low2.78
  • 52 Week Low Date07/07/23

Key Stats

  • Market Cap28.237M
  • Shares Out5.43M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.06
  • YTD % Change10.64

KEY STATS

  • Open5.20
  • Day High5.20
  • Day Low5.00
  • Prev Close5.35
  • 52 Week High8.85
  • 52 Week High Date03/01/24
  • 52 Week Low2.78
  • 52 Week Low Date07/07/23
  • Market Cap28.237M
  • Shares Out5.43M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.06
  • YTD % Change10.64

RATIOS/PROFITABILITY

  • EPS (TTM)-3.99
  • P/E (TTM)-1.30
  • Fwd P/E (NTM)-1.63
  • EBITDA (TTM)-15.465M
  • ROE (TTM)-67.08%
  • Revenue (TTM)583,239.973
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,449.55%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aprea Therapeutics Inc

 

Profile

MORE
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality. The Company's advanced synthetic lethality product candidate is ATRN-119, a clinical-stage small molecule inhibitor of ataxia telangiectasia and Rad3-related (ATR) a kinase that plays a critical role in DNA damage response (DDR). ATR and Checkpoint Kinase 1 are critical DDR kinases that prevent the collapse of replication forks into DNA...
Richard Peters M.D., Ph.D.
Independent Chairman of the Board
Oren Gilad Ph.D.
President, Chief Executive Officer, Director
John Hamill
Chief Financial Officer, Senior Vice President, Secretary
Address
3805 OLD EASTON ROAD
Doylestown, PA
18902
United States

Top Peers

SYMBOLLASTCHG%CHG
FEMY
Femasys Inc
1.27-0.06-4.51%
EYEN
Eyenovia Inc
0.6282-0.0831-11.6828%
TARA
Protara Therapeutics Inc
2.92-0.12-4.10%
INKT
Mink Therapeutics Inc
0.9275+0.0563+6.4624%
IINN
Inspira Technologies Oxy BHN Ltd
1.89+0.01+0.53%